TMEM87B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.546790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.090440E-01
Normal-vs-Stage2
1.945000E-01
Normal-vs-Stage3
5.309800E-02
Normal-vs-Stage4
8.353200E-01
Stage1-vs-Stage2
3.783800E-01
Stage1-vs-Stage3
2.418400E-01
Stage1-vs-Stage4
1.622010E-01
Stage2-vs-Stage3
5.672300E-02
Stage2-vs-Stage4
2.665200E-01
Stage3-vs-Stage4
6.936100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.162210E-01
Normal-vs-AfricanAmerican
7.866800E-01
Normal-vs-Asian
3.805000E-01
Caucasian-vs-AfricanAmerican
1.231170E-01
Caucasian-vs-Asian
6.085800E-01
AfricanAmerican-vs-Asian
4.826200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.814030E-01
Normal-vs-Female
1.431360E-01
Male-vs-Female
7.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.439600E-01
Normal-vs-Age(41-60Yrs)
2.962800E-01
Normal-vs-Age(61-80Yrs)
1.406840E-01
Normal-vs-Age(81-100Yrs)
3.451800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.132600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.249600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.455600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.826500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.192300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.680600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.024630E-01
Normal-vs-Daily Drinker
7.103900E-02
Normal-vs-Weekly Drinker
3.460800E-01
Normal-vs-Occasional Drinker
4.042600E-01
Normal-vs-Social Drinker
1.290590E-01
Non Drinker-vs-Daily Drinker
4.525600E-01
Non Drinker-vs-Weekly Drinker
3.493600E-01
Non Drinker-vs-Occasional Drinker
9.574300E-02
Non Drinker-vs-Social Drinker
6.947000E-01
Daily Drinker-vs-Weekly Drinker
1.571380E-01
Daily Drinker-vs-Occasional Drinker
3.211900E-02
Daily Drinker-vs-Social Drinker
3.116800E-01
Weekly Drinker-vs-Occasional Drinker
6.303600E-01
Weekly Drinker-vs-Social Drinker
5.928000E-01
Occasional Drinker-vs-Social Drinker
2.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.585200E-01
Normal-vs-Grade 2
1.184840E-01
Normal-vs-Grade 3
1.303780E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.138500E-02
Grade 1-vs-Grade 3
6.248500E-02
Grade 1-vs-Grade 4
4.585200E-01
Grade 2-vs-Grade 3
7.341600E-01
Grade 2-vs-Grade 4
1.184840E-01
Grade 3-vs-Grade 4
1.303780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.414400E-02
Normal-vs-NonDiabetic
1.595020E-01
Diabetic-vs-NonDiabetic
3.165700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.203600E-02
Normal-vs-NoPancreatitis
1.507000E-01
Pancreatitis-vs-NoPancreatitis
1.075170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.215410E-01
Normal-vs-N1
1.889830E-01
N0-vs-N1
2.723600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.004000E-01
Normal-vs-TP53-NonMutant
1.570770E-01
TP53-Mutant-vs-TP53-NonMutant
2.464900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
